Beacon Pointe Advisors, LLC Sarepta Therapeutics, Inc. Transaction History
Beacon Pointe Advisors, LLC
- $8.76 Billion
- Q1 2025
A detailed history of Beacon Pointe Advisors, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Beacon Pointe Advisors, LLC holds 3,188 shares of SRPT stock, worth $50,466. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,188
Previous 3,184
0.13%
Holding current value
$50,466
Previous $387,000
47.55%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding SRPT
# of Institutions
493Shares Held
89.6MCall Options Held
1.39MPut Options Held
1.11M-
Black Rock Inc. New York, NY10.3MShares$163 Million0.04% of portfolio
-
Capital International Investors Los Angeles, CA9.06MShares$143 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.03MShares$143 Million0.01% of portfolio
-
State Street Corp Boston, MA4.07MShares$64.4 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X03.36MShares$53.3 Million0.12% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $1.39B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...